CoagulationDisorders near Neptune, NJ

Biography: Dr. Seth Howard Berk specializes in hematology/oncology, and is board certified in internal medicine, hematology and oncology. For more than 13 years, he has been treating patients in the Mount Holly community. Dr. Berk is the Section Chief of hematology/oncology at Virtua Memorial Hospital, Assistant Chairman of the Department of Medicine and Co-Chairman of the Internal Medicine Physician Peer Review Committee. He is actively involved in enrolling patients in clinical trials. Dr. Berk received his medical degree from Columbia University College of Physicians and Surgeons. He completed his residency at Columbia Presbyterian Medical Center in internal medicine and conducted his fellowship in both hematology and oncology at the Hospital of the University of Chicago. He was involved in both clinical and laboratory research, where his focus was in the development of new chemotherapy agents to treat a variety of cancers. Dr. Berk holds is a member of the Medical Society of New Jersey, American Society of Clinical Oncology, and American Society of Hematology.

Care Philosophy: ``The diagnosis of cancer can be very hard on both patients and families. As their physician, I provide each patient with a personalized treatment option based on current evidence. I empower my patients to be an active decision maker in their treatment Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Care Philosophy: For over a decade I have been taking care of people with lymphoma. At the end of every visit, I want people to know that I have taken the time to develop the plan that is the best for them. I am fortunate to work in a center where cancer care specialists can work along side experts in every field of medicine to care for the whole person. We are working every day to develop better treatments and integrate them into clinical practice. We have been involved in the development of virtually every drug approved for treatment of lymphoma over the past 15 years, including targeted therapies and immunotherapy. In our labs and our clinics we are developing the drugs of the future. We have made a lot of progress in the way lymphoma is diagnosed and treated, and I am determined to continue developing more effective, less toxic therapies.

Care Philosophy: Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.